The landscape of the healthcare industry is rapidly evolving, making the shift towards value-based care, technological innovation, and strategic collaboration more critical than ever. Mergers and acquisitions (M&A) have become vital tools for healthcare providers seeking to adapt and thrive in this dynamic environment.
Clients involved in health care transactions need a trusted legal and business partner, an experienced law firm that understands not only their healthcare business but also the legal intricacies of the deal. Our M&A attorneys work in close collaboration with our clients, striving to gain a comprehensive understanding of their opportunities, vulnerabilities and objectives. This enables us to provide guidance at both the operational and strategic levels.
How We Help Our Clients
Turning these innovative and transformative business ventures into reality involves grappling with substantial regulatory and transactional hurdles, with numerous chances for a deal to deviate from its intended path. Our transaction leaders bring highly focused skills and broad industry experience to bear on all elements of a transaction.
Our extensive experience in healthcare M&A has earned us a deep understanding of the nuances that can make or break a deal. We pride ourselves on our ability to execute transactions smoothly and efficiently, minimizing risks while maximizing value for our clients. Our team works diligently to anticipate potential roadblocks and develop proactive solutions, ensuring that transactions progress without unnecessary delays or costs.
Navigating the maze of healthcare regulations is no small feat. From compliance with the Stark Law to understanding the intricacies of Medicare reimbursement, our team is well-versed in the regulatory challenges that healthcare M&A presents. We offer comprehensive guidance to ensure that your transaction is not just successful, but also compliant with all relevant federal and state laws.
In the complex world of healthcare M&A, a multi-disciplinary approach is often required for success. Our team integrates expertise in regulatory compliance, transactional law, and tax planning to offer a truly comprehensive service. This cross-functional approach allows us to address the unique challenges of each transaction from multiple angles, ensuring a more robust and effective strategy.
Comprehensive Services
We offer end-to-end M&A services that cover the entire transaction lifecycle. From initial due diligence to post-transaction integration, our team is prepared to help you every step of the way. We provide counsel on deal structuring, negotiation, and regulatory compliance, ensuring that your merger or acquisition is executed seamlessly.
In addition to traditional M&A, we also facilitate private equity and venture capital investments in the healthcare and life sciences sectors. Whether you are an investor seeking opportunities or a healthcare business looking for growth capital, Frier Levitt offers tailored solutions that meet your specific needs.
Forming a joint venture or entering into a strategic alliance can be an effective way to achieve specific business objectives. Our team provides guidance on structuring these complex arrangements, ensuring that they are not only legally sound but also strategically advantageous.
Representative Matters
Seven years after forming and structuring a state-wide retina practice, and creating a growth model to incorporate general ophthalmology, Frier Levitt guided the client through one of the largest private equity backed purchases of a medical practice in the State of New Jersey.
Advised an independent insurance agency based in NYC and licensed in 40 states, and its owner in two transactions:
- Long-term contract with a Canadian firm to act as company’s exclusive U.S. partner.
- Sale of company to a private equity firm. In connection with the sale, the owner entered into long-term employment and earnout arrangements and also invested part of his stake in the fund that owns company which is one of the nation’s largest and fastest-growing financial product distribution companies, focused on the retirement-planning and wealth advisory businesses.
Represented a healthcare technology company in the recapitalization of another healthcare technology AI company. Frier Levitt handled the original investment and license.
Served as transactional and regulatory counsel for a 200+ provider, Connecticut-based OB/GYN practice in an asset sale to a private equity-backed management services organization for $63,400,000 cash plus rollover equity in parent company. Subsequent representation of practice in a second recapitalization.
After restructuring the practice, and creating a management services organization (MSO), negotiated the sale of a 51% equity interest to large non-profit health system in the practice, and a minority ownership interest in the MSO.
Representation of private equity group in creation of MSO and purchase of multiple hair transplant medical practices in multiple states. Additional acquisitions pending.
Served as transactional and regulatory counsel on behalf of 150+ provider, New Jersey platform OB/GYN practice in connection with a sale to a private equity-backed management services organization for over $46 million cash plus rollover equity in parent company.
Served as transactional and regulatory counsel on behalf of a Nevada platform OB/GYN practice and its affiliated management services organization in connection with the sale of 50% equity in the affiliated MSO for $28,665,000.
Served as transactional and regulatory counsel on behalf of a Texas OB/GYN practice in connection with the merger of the practice with physician platform for $10,960,000 cash plus rollover equity in a regional MSO.
Served as transactional and regulatory counsel on behalf of a New Jersey ambulatory surgery center in connection with the sale of a 51% equity to private equity-backed to a private equity-backed management services organization for $11,000,000.
Served as transactional and regulatory counsel on behalf of a New Jersey ambulatory surgery center in connection with the sale of a 51% equity to a private equity-backed management services organization for $10,665,000.
Served as transactional and regulatory counsel on behalf of a New Jersey platform pediatric practice in connection with a reorganization and sale of 51% equity to a major health system for over $13 million.
Currently serving as transactional and regulatory counsel on behalf of a New Jersey platform gastroenterology practice and its affiliated management services organization in connection with a sale and merger to a major health system for over $26 million.
Successfully closed a $15 million sale of a residential rehabilitation facility in Scottsdale, AZ. A week after the closing, the broker on the deal called to recommend us to another one of her clients who is selling a non-emergency medical transport company in Buffalo, NY for $11 million.
Represented the Seller in a complex $18 million transaction involving the sale of the dental implant practice, including $4 million in rollover equity, $4 million earnout payable over two years, and $4 million retention payable in year three.
Why Frier Levitt
As a leading law firm focusing exclusively on healthcare and life sciences, Frier Levitt offers unparalleled experience and a proven track record in Medical Practice M&A. With numerous successful transactions and a deep understanding of both federal and state regulatory landscapes, we are your trusted partner in navigating the complexities of healthcare M&A. Our unwavering commitment to excellence ensures that you receive not just legal advice, but strategic counsel that aligns with your long-term objectives.
How Frier Levitt Can Help
Frier Levitt provides strategic, industry-focused legal counsel tailored to your needs. Contact our team today to learn how we can help you.